Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2000;93(Suppl 38):40–45.

Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

J R Govan 1
PMCID: PMC1305883  PMID: 10911818

Full Text

The Full Text of this article is available as a PDF (83.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams C., Morris-Quinn M., McConnell F., West J., Lucey B., Shortt C., Cryan B., Watson J. B., O'Gara F. Epidemiology and clinical impact of Pseudomonas aeruginosa infection in cystic fibrosis using AP-PCR fingerprinting. J Infect. 1998 Sep;37(2):151–158. doi: 10.1016/s0163-4453(98)80170-9. [DOI] [PubMed] [Google Scholar]
  2. Austin D. J., Anderson R. M. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J Infect Dis. 1999 Apr;179(4):883–891. doi: 10.1086/314682. [DOI] [PubMed] [Google Scholar]
  3. Ayliffe G. A., Babb J. R., Collins B. J., Lowbury E. J., Newsom S. W. Pseudomonas aeruginosa in hospital sinks. Lancet. 1974 Sep 7;2(7880):578–581. doi: 10.1016/s0140-6736(74)91893-5. [DOI] [PubMed] [Google Scholar]
  4. Boucher R. C. Molecular insights into the physiology of the 'thin film' of airway surface liquid. J Physiol. 1999 May 1;516(Pt 3):631–638. doi: 10.1111/j.1469-7793.1999.0631u.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Boxerbaum B., Jacobs M. R., Cechner R. L. Prevalence and significance of methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. Pediatr Pulmonol. 1988;4(3):159–163. doi: 10.1002/ppul.1950040307. [DOI] [PubMed] [Google Scholar]
  6. Cazzola G., Amalfitano G., Tonolli E., Perazzoli C., Piacentini I., Mastella G. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study. Acta Paediatr. 1996 May;85(5):554–557. doi: 10.1111/j.1651-2227.1996.tb14085.x. [DOI] [PubMed] [Google Scholar]
  7. Cheng K., Smyth R. L., Govan J. R., Doherty C., Winstanley C., Denning N., Heaf D. P., van Saene H., Hart C. A. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996 Sep 7;348(9028):639–642. doi: 10.1016/S0140-6736(96)05169-0. [DOI] [PubMed] [Google Scholar]
  8. Cox R. A., Conquest C. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect. 1997 Feb;35(2):117–127. doi: 10.1016/s0195-6701(97)90100-6. [DOI] [PubMed] [Google Scholar]
  9. Drabick J. A., Gracely E. J., Heidecker G. J., LiPuma J. J. Survival of Burkholderia cepacia on environmental surfaces. J Hosp Infect. 1996 Apr;32(4):267–276. doi: 10.1016/s0195-6701(96)90037-7. [DOI] [PubMed] [Google Scholar]
  10. Drittanti L., Masciovecchio M. V., Gabbarini J., Vega M. Cystic fibrosis: gene therapy or preventive gene transfer? Gene Ther. 1997 Oct;4(10):1001–1003. doi: 10.1038/sj.gt.3300526. [DOI] [PubMed] [Google Scholar]
  11. Gilligan P. H. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev. 1991 Jan;4(1):35–51. doi: 10.1128/cmr.4.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Govan J. R., Brown P. H., Maddison J., Doherty C. J., Nelson J. W., Dodd M., Greening A. P., Webb A. K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993 Jul 3;342(8862):15–19. doi: 10.1016/0140-6736(93)91881-l. [DOI] [PubMed] [Google Scholar]
  13. Govan J. R., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996 Sep;60(3):539–574. doi: 10.1128/mr.60.3.539-574.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Govan J. R., Hughes J. E., Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996 Dec;45(6):395–407. doi: 10.1099/00222615-45-6-395. [DOI] [PubMed] [Google Scholar]
  15. Govan J. R., Nelson J. W. Microbiology of lung infection in cystic fibrosis. Br Med Bull. 1992 Oct;48(4):912–930. doi: 10.1093/oxfordjournals.bmb.a072585. [DOI] [PubMed] [Google Scholar]
  16. Grothues D., Koopmann U., von der Hardt H., Tümmler B. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J Clin Microbiol. 1988 Oct;26(10):1973–1977. doi: 10.1128/jcm.26.10.1973-1977.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Guidelines on the control of methicillin-resistant Staphylococcus aureus in the community. Report of a combined Working Party of the British Society for Antimicrobial Chemotherapy and the Hospital Infection Society. J Hosp Infect. 1995 Sep;31(1):1–12. [PubMed] [Google Scholar]
  18. Henry D. A., Campbell M. E., LiPuma J. J., Speert D. P. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol. 1997 Mar;35(3):614–619. doi: 10.1128/jcm.35.3.614-619.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Henry D., Campbell M., McGimpsey C., Clarke A., Louden L., Burns J. L., Roe M. H., Vandamme P., Speert D. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1999 Apr;37(4):1004–1007. doi: 10.1128/jcm.37.4.1004-1007.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Henry R. L., Mellis C. M., Petrovic L. Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis. Pediatr Pulmonol. 1992 Mar;12(3):158–161. doi: 10.1002/ppul.1950120306. [DOI] [PubMed] [Google Scholar]
  21. Holmes A., Nolan R., Taylor R., Finley R., Riley M., Jiang R. Z., Steinbach S., Goldstein R. An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis. 1999 May;179(5):1197–1205. doi: 10.1086/314699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hoogkamp-Korstanje J. A., Meis J. F., Kissing J., van der Laag J., Melchers W. J. Risk of cross-colonization and infection by Pseudomonas aeruginosa in a holiday camp for cystic fibrosis patients. J Clin Microbiol. 1995 Mar;33(3):572–575. doi: 10.1128/jcm.33.3.572-575.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hutchison M. L., Govan J. R. Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect. 1999 Oct;1(12):1005–1014. doi: 10.1016/s1286-4579(99)80518-8. [DOI] [PubMed] [Google Scholar]
  24. Isles A., Maclusky I., Corey M., Gold R., Prober C., Fleming P., Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984 Feb;104(2):206–210. doi: 10.1016/s0022-3476(84)80993-2. [DOI] [PubMed] [Google Scholar]
  25. Jensen E. T., Giwercman B., Ojeniyi B., Bangsborg J. M., Hansen A., Koch C., Fiehn N. E., Høiby N. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment. J Hosp Infect. 1997 Jun;36(2):117–122. doi: 10.1016/s0195-6701(97)90117-1. [DOI] [PubMed] [Google Scholar]
  26. Kubesch P., Lingner M., Grothues D., Wehsling M., Tümmler B. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung. Scand J Gastroenterol Suppl. 1988;143:77–80. [PubMed] [Google Scholar]
  27. Ledson M. J., Gallagher M. J., Corkill J. E., Hart C. A., Walshaw M. J. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax. 1998 May;53(5):432–436. doi: 10.1136/thx.53.5.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ledson M. J., Gallagher M. J., Walshaw M. J. Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax. 1998 May;53(5):430–432. doi: 10.1136/thx.53.5.430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lessing M. P., Jordens J. Z., Bowler I. C. When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus? J Hosp Infect. 1996 Nov;34(3):205–210. doi: 10.1016/s0195-6701(96)90067-5. [DOI] [PubMed] [Google Scholar]
  30. LiPuma J. J. Burkholderia cepacia. Management issues and new insights. Clin Chest Med. 1998 Sep;19(3):473-86, vi. doi: 10.1016/s0272-5231(05)70094-0. [DOI] [PubMed] [Google Scholar]
  31. Mahadeva R., Webb K., Westerbeek R. C., Carroll N. R., Dodd M. E., Bilton D., Lomas D. A. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998 Jun 13;316(7147):1771–1775. doi: 10.1136/bmj.316.7147.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mahenthiralingam E., Coenye T., Chung J. W., Speert D. P., Govan J. R., Taylor P., Vandamme P. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol. 2000 Feb;38(2):910–913. doi: 10.1128/jcm.38.2.910-913.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mahenthiralingam E., Simpson D. A., Speert D. P. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol. 1997 Apr;35(4):808–816. doi: 10.1128/jcm.35.4.808-816.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Matsui H., Grubb B. R., Tarran R., Randell S. H., Gatzy J. T., Davis C. W., Boucher R. C. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell. 1998 Dec 23;95(7):1005–1015. doi: 10.1016/s0092-8674(00)81724-9. [DOI] [PubMed] [Google Scholar]
  35. Nelson J. W., Tredgett M. W., Sheehan J. K., Thornton D. J., Notman D., Govan J. R. Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization in cystic fibrosis. Infect Immun. 1990 Jun;58(6):1489–1495. doi: 10.1128/iai.58.6.1489-1495.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pamukcu A., Bush A., Buchdahl R. Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulmonol. 1995 Jan;19(1):10–15. doi: 10.1002/ppul.1950190103. [DOI] [PubMed] [Google Scholar]
  37. Pedersen S. S., Koch C., Høiby N., Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J Antimicrob Chemother. 1986 Apr;17(4):505–516. doi: 10.1093/jac/17.4.505. [DOI] [PubMed] [Google Scholar]
  38. Renders N. H., Sijmons M. A., van Belkum A., Overbeek S. E., Mouton J. W., Verbrugh H. A. Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings. Res Microbiol. 1997 Jun;148(5):447–454. doi: 10.1016/s0923-2508(97)83875-2. [DOI] [PubMed] [Google Scholar]
  39. Sajjan S. U., Forstner J. F. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis. Infect Immun. 1992 Apr;60(4):1434–1440. doi: 10.1128/iai.60.4.1434-1440.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sajjan U. S., Corey M., Karmali M. A., Forstner J. F. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J Clin Invest. 1992 Feb;89(2):648–656. doi: 10.1172/JCI115631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sajjan U. S., Sun L., Goldstein R., Forstner J. F. Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol. 1995 Feb;177(4):1030–1038. doi: 10.1128/jb.177.4.1030-1038.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Speert D. P., Campbell M. E. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis. J Hosp Infect. 1987 Jan;9(1):11–21. doi: 10.1016/0195-6701(87)90089-2. [DOI] [PubMed] [Google Scholar]
  43. Speert D. P., Lawton D., Damm S. Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp. J Pediatr. 1982 Aug;101(2):227–228. doi: 10.1016/s0022-3476(82)80127-3. [DOI] [PubMed] [Google Scholar]
  44. Sun L., Jiang R. Z., Steinbach S., Holmes A., Campanelli C., Forstner J., Sajjan U., Tan Y., Riley M., Goldstein R. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med. 1995 Jul;1(7):661–666. doi: 10.1038/nm0795-661. [DOI] [PubMed] [Google Scholar]
  45. Tredgett M. W., Doherty C., Govan J. R. Incidence of common pyocin types of Pseudomonas aeruginosa from patients with cystic fibrosis and chronic airways diseases. J Med Microbiol. 1990 Jul;32(3):169–172. doi: 10.1099/00222615-32-3-169. [DOI] [PubMed] [Google Scholar]
  46. Tümmler B., Koopmann U., Grothues D., Weissbrodt H., Steinkamp G., von der Hardt H. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients. J Clin Microbiol. 1991 Jun;29(6):1265–1267. doi: 10.1128/jcm.29.6.1265-1267.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Vandamme P., Holmes B., Vancanneyt M., Coenye T., Hoste B., Coopman R., Revets H., Lauwers S., Gillis M., Kersters K. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997 Oct;47(4):1188–1200. doi: 10.1099/00207713-47-4-1188. [DOI] [PubMed] [Google Scholar]
  48. Webb A. K., Egan J. Should patients with cystic fibrosis infected with Burkholderia cepacia undergo lung transplantation? Thorax. 1997 Aug;52(8):671–673. doi: 10.1136/thx.52.8.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Webb A. K., Govan J. R. Burkholderia cepacia: another twist and a further threat. Thorax. 1998 May;53(5):333–334. doi: 10.1136/thx.53.5.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Zembrzuska-Sadkowska E., Sneum M., Ojeniyi B., Heiden L., Høiby N. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre. J Hosp Infect. 1995 Jan;29(1):1–7. doi: 10.1016/0195-6701(95)90288-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES